US Lawyer Database

Section 151.555 — Prescription Drug Repository Program.

151.555 PRESCRIPTION DRUG REPOSITORY PROGRAM. Subdivision 1. Definitions. (a) For the purposes of this section, the terms defined in this subdivision have the meanings given. (b) “Central repository” means a wholesale distributor that meets the requirements under subdivision 3 and enters into a contract with the Board of Pharmacy in accordance with this section. (c) […]

Section 151.56 — County Return Of Unused Drugs Or Medical Devices.

151.56 COUNTY RETURN OF UNUSED DRUGS OR MEDICAL DEVICES. Notwithstanding Minnesota Rules, part 6800.2700, pharmacies may accept returns of and redispense unopened, unused drugs in board-approved unit dose packaging and medical devices from county jails and juvenile correctional facilities. In order to return unused drugs and medical devices, the county jail or juvenile correctional facility […]

Section 151.58 — Automated Drug Distribution Systems.

151.58 AUTOMATED DRUG DISTRIBUTION SYSTEMS. Subdivision 1. Scope. This section applies only to the use of automated drug distribution systems located within the facilities specified in subdivision 2. Except as provided in this section, all applicable provisions of this chapter, chapter 152, and Minnesota Rules, chapter 6800, must be followed. Subd. 2. Definitions. For purposes […]

Section 151.72 — Sale Of Certain Cannabinoid Products.

151.72 SALE OF CERTAIN CANNABINOID PRODUCTS. Subdivision 1. Definitions. (a) For the purposes of this section, the following terms have the meanings given. (b) “Certified hemp” means hemp plants that have been tested and found to meet the requirements of chapter 18K and the rules adopted thereunder. (c) “Edible cannabinoid product” means any product that […]

Section 151.74 — Insulin Safety Net Program.

151.74 INSULIN SAFETY NET PROGRAM. Subdivision 1. Establishment. (a) By July 1, 2020, each manufacturer must establish procedures to make insulin available in accordance with this section to eligible individuals who are in urgent need of insulin or who are in need of access to an affordable insulin supply. (b) For purposes of this section, […]

Section 151.38 — Embargoes.

151.38 EMBARGOES. (1) Whenever a duly authorized agent of the board finds or has probable cause to believe that any drug or medicine is adulterated, or so misbranded as to be dangerous or fraudulent, or is being sold, delivered, or offered for sale in violation of section 151.361, the agent shall affix thereto an appropriate […]

Section 151.39 — Distressed Drugs.

151.39 DISTRESSED DRUGS. Subdivision 1. Definition. Distressed drugs shall mean drugs or medicines which have been subjected to accident, fire, flood, adverse temperatures, or other physical influences which could affect the potency, quality, purity, or efficacy of such drug or medicine could otherwise cause the drug or medicine to be adulterated or misbranded within the […]

Section 151.40 — Possession And Sale Of Hypodermic Syringes And Needles.

151.40 POSSESSION AND SALE OF HYPODERMIC SYRINGES AND NEEDLES. Subdivision 1. Generally. It is unlawful for any person to possess, control, manufacture, sell, furnish, dispense, or otherwise dispose of hypodermic syringes or needles or any instrument or implement which can be adapted for subcutaneous injections, except for: (1) the following persons when acting in the […]

Section 151.415 — Long-term Care Resident Access To Pharmaceuticals Act.

151.415 LONG-TERM CARE RESIDENT ACCESS TO PHARMACEUTICALS ACT. Subdivision 1. Title; citation. This section may be cited as the “Long-Term Care Resident Access to Pharmaceuticals Act.” Subd. 2. Definitions. For the purposes of this section, the following terms have the meanings given them unless otherwise provided by text: (a) “Board” means the Board of Pharmacy. […]

Section 151.43 — Scope.

151.43 SCOPE. Sections 151.43 to 151.471 apply to any person engaging in the wholesale distribution of drugs within the state and to persons operating as third-party logistics providers. History: 1990 c 526 s 6; 1990 c 568 art 2 s 21; 1Sp2019 c 9 art 10 s 43; 2020 c 83 art 1 s 42